Establishment of a Web-based System for Collection of Patient-reported Outcomes After Radical Prostatectomy in a Statewide Quality Improvement Collaborative

Lucas, Steven M.; Kim, Tae‐Kyung; Ghani, Khurshid R.; Miller, David C.; Linsell, Susan; Starr, Jay; Peabody, James O.; Hurley, Patrick; Montie, James E.; Cher, Michael L.

doi:10.1016/j.urology.2017.04.058

Cited by 27 publications

(42 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This objective led to development of the MUSIC Patient-Reported Outcomes (MUSIC-PRO), a statewide Web-based system for measuring outcomes and HRQOL after radical prostatectomy. 23 Each MUSIC practice has an exemption or approval for collaborative participation from a local institutional review board.…”

Section: Study Setting and Designmentioning

confidence: 99%

“…MUSIC-PRO. The initial MUSIC-PRO survey 23 used the Memorial Sloan Kettering Cancer Center (MSKCC) questionnaire, the IIEF-6, PROMIS questions on interest and satisfaction, including single-item measures from the PROMIS Interest in Sexual Activity and Global Satisfaction With Sex Life subdomains. The surveys were administered at baseline (before radical prostatectomy) and 3, 6, 12, and 24 months after radical prostatectomy.…”

Section: Promis Single Items From the Promis Interest In Sexualmentioning

confidence: 99%

See 1 more Smart Citation

Validity of the Patient-Reported Outcome Measurement Information System (PROMIS) Sexual Interest and Satisfaction Measures in Men Following Radical Prostatectomy

Agochukwu

Wittmann

Boileau³

et al. 2019

JCO

Self Cite

View full text Add to dashboard Cite

PURPOSE Patient-reported outcomes after radical prostatectomy have focused on erectile function. To date, no studies have validated the Patient-Reported Outcome Measurement Information System (PROMIS) Sexual Interest and Satisfaction single item measures in patients with prostate cancer, nor have studies examined how these measures relate to erectile function. In addition, data are lacking with regard to the clinical responsiveness of these measures to treatment. We sought to validate and examine the clinical utility of these measures in men after radical prostatectomy. PATIENTS AND METHODS We identified men who underwent a robotic radical prostatectomy from May 2014 to January 2016 in the Michigan Urological Surgery Improvement Collaborative. A single item from the PROMIS Global Satisfaction With Sex Life subdomain and a single item from the PROMIS Interest in Sexual Activity subdomain were administered. Erectile function was also assessed. Differences between baseline and 24-month T-scores for both PROMIS interest and satisfaction were examined. Multilevel models were constructed to examine change over time. RESULTS A total of 1,604 patients were included in the analysis. Convergent and discriminant validity of the PROMIS measures was supported. The mean PROMIS interest T-score decreased significantly from baseline to 3 months ( P = .001) and significantly increased from 3 months to 24 months in this cohort, with 24-month scores exceeding baseline scores ( P < .001). The mean PROMIS satisfaction T-score declined from baseline to 3 months and increased from 3 months to 24 months ( P < .002). CONCLUSION PROMIS Global Satisfaction With Sex Life and Interest in Sexual Activity single-item measures are fundamental measures in prostate cancer survivorship. Patients are interested in sex despite functional losses and can salvage satisfaction, thereby giving insight into attainable patient-centered survivorship goals for sexual recovery after radical prostatectomy.

show abstract

Section: Study Setting and Designmentioning

confidence: 99%

Section: Promis Single Items From the Promis Interest In Sexualmentioning

confidence: 99%

Validity of the Patient-Reported Outcome Measurement Information System (PROMIS) Sexual Interest and Satisfaction Measures in Men Following Radical Prostatectomy

Agochukwu

Wittmann

Boileau³

et al. 2019

JCO

Self Cite

View full text Add to dashboard Cite

show abstract

“…One study reported that 8 out of 92 participants actually had their family caregivers who reported their symptoms for them, whereas there was no information provided regarding caregivers' acceptance and use in this study [30]. Study durations ranged from 1 month to 24 months, of which 7 studies (7/33, 21%) [31][32][33][34][35][36][37] followed up with participants for more than 6 months (Multimedia Appendix 2).…”

Section: Summary Of Study Characteristicsmentioning

confidence: 99%

“…In total, 17 web-based e-SRS were reported in 22 studies (22/33, 66%) [27][28][29][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49], including 2 studies that integrated web-based platforms with patient portals and electronic health records (EHRs) [41,47]. A total of 9 studies presented 7 mobile app-based e-SRS (9/33, 27%) [30,[50][51][52][53][54][55][56][57], 1 study reported an interactive voice response system [58], and 1 study used only text messaging for symptom reporting [59].…”

Section: Summary Of Study Characteristicsmentioning

confidence: 99%

Acceptance and Use of Home-Based Electronic Symptom Self-Reporting Systems in Patients With Cancer: Systematic Review

Cho¹,

Zhang²,

Harris³

et al. 2021

J Med Internet Res

View full text Add to dashboard Cite

Background Electronic symptom self-reporting systems (e-SRS) have been shown to improve symptoms and survival in patients with cancer. However, patient engagement in using e-SRS for voluntary symptom self-reporting is less optimal. Multiple factors can potentially affect patients’ acceptance and engagement in using home-based e-SRS. However, such factors have not been fully explored in cancer populations. Objective The aim of this study is to understand the acceptance and use of home-based e-SRS by patients with cancer and identify associated facilitators and barriers. Methods PubMed, CINAHL, Scopus, and PsycINFO (January 2010 to March 2020) were searched using a combination of Medical Subject Headings (MeSH) terms and keywords such as symptom self-reporting, electronic/technology, cancer, and their synonyms. Included studies focused on the use of home-based e-SRS by patients with cancer and their families. Studies on patients’ use of e-SRS in clinical settings only were excluded. Of the 3740 papers retrieved, 33 were included in the final review. Factors associated with patient acceptance and use of e-SRS were extracted and synthesized. Results Most e-SRS were web based (22/33, 66%) or mobile app based (9/33, 27%). The e-SRS initial acceptance, represented by patient enrollment rates, ranged from 40% (22/55) to 100% (100/100). High e-SRS acceptance was rated by 69% (59/85) to 77.6% (337/434) of the patients after they used the system. The e-SRS use, measured by patients’ response rates to questionnaires (ranging from 1596/3521, 45.33% to 92%) or system log-on rates (ranging from 4/12, 33% to 99/100, 99%), declined over time in general patterns. Few studies (n=7) reported e-SRS use beyond 6 months, with the response rates ranging from 62% (40/64) to 85.1% (541/636) and the log-on rates ranging from 63.6% (103/162) to 77% (49/64). The availability of compatible devices and technical support, interactive system features, information accessibility, privacy, questionnaire quality, patient physical/psychosocial status, and age were associated with patient acceptance and use of home-based e-SRS. Conclusions Acceptance and use of home-based e-SRS by patients with cancer varied significantly across studies, as assessed by a variety of approaches. The lack of access to technology has remained a barrier to e-SRS adoption. Interactive system features and personalized questionnaires may increase patient engagement. More studies are needed to further understand patients’ long-term use of home-based e-SRS behavior patterns to develop personalized interventions to support symptom self-management and self-reporting of patients with cancer for optimal health outcomes.

show abstract

“…PROMs are particularly important in care for patients with prostate cancer (PCa) since the chances of long-term survival are very good [6], whereas impairment of functional status (FS) may be substantial [7]. Many initiatives such as the Michigan Urological Surgery Improvement Collaborative and the Martini-Klinik program have already implemented collection of PROM data in routine care for PCa patients [8,9]. However, such approaches are often isolated or involve programs that are limited to single locations or regions.…”

Section: Introductionmentioning

confidence: 99%

Determinants of self-reported functional status (EPIC-26) in prostate cancer patients prior to treatment

Rothschild

Dieng²,

Oesterle³

et al. 2020

World J Urol

View full text Add to dashboard Cite

Purpose The self-reported functional status (sr-FS) of prostate cancer (PCa) patients varies substantially between patients and health-care providers before treatment. Information about this issue is important for evaluating comparisons between health-care providers and to assist in treatment decision-making. There have been few reports on correlates of pretherapeutic sr-FS. The objective of the article, therefore, is to describe clinical and sociodemographic correlates of pretherapeutic sr-FS, based on a subset of the TrueNTH Global Registry, a prospective cohort study. Methods A total of 3094 PCa patients receiving local treatment in 44 PCa centers in Germany were recruited between July 2016 and April 2018. Multilevel regression models were applied to predict five pretherapeutic sr-FS (EPIC-26) scores based on clinical characteristics (standard set suggested by the International Consortium for Health Outcomes Measurement), sociodemographic characteristics, and center characteristics. Results Impaired pretherapeutic sr-FS tended to be associated with lower educational level and poorer disease characteristics-except for "urinary incontinence" which was only associated with age. Notably, age was a risk factor ("urinary incontinence," "urinary irritative/obstructive," "sexual") as well as a protective factor ("hormonal") for pretherapeutic sr-FS. Pretherapeutic sr-FS varies little across centers. Conclusions Pretherapeutic sr-FS varies by clinical patient characteristics and age as well as by socioeconomic status. The findings point out the benefit of collecting and considering socioeconomic information in addition to clinical and demographic patient characteristics for treatment decision-making and fair comparisons between health-care providers.

show abstract

Establishment of a Web-based System for Collection of Patient-reported Outcomes After Radical Prostatectomy in a Statewide Quality Improvement Collaborative

Cited by 27 publications

References 22 publications

Validity of the Patient-Reported Outcome Measurement Information System (PROMIS) Sexual Interest and Satisfaction Measures in Men Following Radical Prostatectomy

Validity of the Patient-Reported Outcome Measurement Information System (PROMIS) Sexual Interest and Satisfaction Measures in Men Following Radical Prostatectomy

Acceptance and Use of Home-Based Electronic Symptom Self-Reporting Systems in Patients With Cancer: Systematic Review

Determinants of self-reported functional status (EPIC-26) in prostate cancer patients prior to treatment

Contact Info

Product

Resources

About